Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruben Pio

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 23, 2012
Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lungMaría J Pajares, Jackeline Agorreta, Marta Larrayoz, et al.
Journal of the National Cancer Institute|August 14, 2013
Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancerDaniel Ajona, María J Pajares, Leticia Corrales, et al.
American Journal of Respiratory and Critical Care Medicine|February 11, 2015
Improving selection criteria for lung cancer screening. The potential role of emphysemaPablo Sanchez-Salcedo, David O Wilson, Juan P de-Torres, et al.
American Journal of Respiratory and Critical Care Medicine|January 13, 2018
Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated EffectsDaniel Ajona, Carolina Zandueta, Leticia Corrales, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|February 22, 2021
A model based on the quantification of complement C4c, CYFRA 21-1 and CRP exhibits high specificity for the early diagnosis of lung cancerDaniel Ajona, Ana Remirez, Cristina Sainz, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|February 23, 2024
Elevated expression of complement factor I in lung cancer cells associates with shorter survival-Potentially via non-canonical mechanismAnna Felberg, Michał Bieńkowski, Tomasz Stokowy, et al.
BMC Genomics|October 8, 2015
Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterationsAnder Aramburu, Isabel Zudaire, María J Pajares, et al.
Plos One|April 12, 2013
Smokers with CT detected emphysema and no airway obstruction have decreased plasma levels of EGF, IL-15, IL-8 and IL-1raJuan P de-Torres, David Blanco, Ana B Alcaide, et al.
Bioengineering & Translational Medicine|September 30, 2022
Design and validation of a tunable inertial microfluidic system for the efficient enrichment of circulating tumor cells in bloodAlejandro Rodríguez-Pena, Estibaliz Armendariz, Alvaro Oyarbide, et al.
The Journal of Pathology|May 15, 2018
A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patientsElena Martínez-Terroba, Carmen Behrens, Fernando J de Miguel, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 23, 2012
Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lungMaría J Pajares, Jackeline Agorreta, Marta Larrayoz, et al.
Journal of the National Cancer Institute|August 14, 2013
Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancerDaniel Ajona, María J Pajares, Leticia Corrales, et al.
American Journal of Respiratory and Critical Care Medicine|February 11, 2015
Improving selection criteria for lung cancer screening. The potential role of emphysemaPablo Sanchez-Salcedo, David O Wilson, Juan P de-Torres, et al.
American Journal of Respiratory and Critical Care Medicine|January 13, 2018
Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated EffectsDaniel Ajona, Carolina Zandueta, Leticia Corrales, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|February 22, 2021
A model based on the quantification of complement C4c, CYFRA 21-1 and CRP exhibits high specificity for the early diagnosis of lung cancerDaniel Ajona, Ana Remirez, Cristina Sainz, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|February 23, 2024
Elevated expression of complement factor I in lung cancer cells associates with shorter survival-Potentially via non-canonical mechanismAnna Felberg, Michał Bieńkowski, Tomasz Stokowy, et al.
BMC Genomics|October 8, 2015
Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterationsAnder Aramburu, Isabel Zudaire, María J Pajares, et al.
Plos One|April 12, 2013
Smokers with CT detected emphysema and no airway obstruction have decreased plasma levels of EGF, IL-15, IL-8 and IL-1raJuan P de-Torres, David Blanco, Ana B Alcaide, et al.
Bioengineering & Translational Medicine|September 30, 2022
Design and validation of a tunable inertial microfluidic system for the efficient enrichment of circulating tumor cells in bloodAlejandro Rodríguez-Pena, Estibaliz Armendariz, Alvaro Oyarbide, et al.
The Journal of Pathology|May 15, 2018
A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patientsElena Martínez-Terroba, Carmen Behrens, Fernando J de Miguel, et al.
Pageof 10